APA (7th ed.) Citation

Nakamura, S., Nagata, M., Nagaya, N., Ashizawa, T., Hirano, H., Lu, Y., . . . Horie, S. (2024). The Detection and Negative Reversion of Circulating Tumor Cells as Prognostic Biomarkers for Metastatic Castration-Resistant Prostate Cancer with Bone Metastases Treated by Enzalutamide. Cancers, 16(4), 772. https://doi.org/10.3390/cancers16040772

Chicago Style (17th ed.) Citation

Nakamura, So, Masayoshi Nagata, Naoya Nagaya, Takeshi Ashizawa, Hisashi Hirano, Yan Lu, Hisamitsu Ide, and Shigeo Horie. "The Detection and Negative Reversion of Circulating Tumor Cells as Prognostic Biomarkers for Metastatic Castration-Resistant Prostate Cancer with Bone Metastases Treated by Enzalutamide." Cancers 16, no. 4 (2024): 772. https://doi.org/10.3390/cancers16040772.

MLA (9th ed.) Citation

Nakamura, So, et al. "The Detection and Negative Reversion of Circulating Tumor Cells as Prognostic Biomarkers for Metastatic Castration-Resistant Prostate Cancer with Bone Metastases Treated by Enzalutamide." Cancers, vol. 16, no. 4, 2024, p. 772, https://doi.org/10.3390/cancers16040772.